Novartis Exjade Review Complicated By Use Of SQUID To Measure Iron Levels
This article was originally published in The Pink Sheet Daily
Executive Summary
Use of superconducting quantum interference device as alternative to biopsy in oral iron chelator trials for iron level measurement led CDER to request consultative review from agency device center, FDA review documents show. Method deemed “inadequate” for accurate measurement.
You may also be interested in...
Novartis Exjade Clears FDA As First Oral Chelating Agent
Novartis receives broad indication for deferasirox for treatment of iron overload in patients over 2 years of age.
Mobile Health Apps Could Disrupt Medical Technology Market– Report
Ernst & Young annual report highlights the importance of emerging “patient-empowering” and “information-leveraging” technologies, and their power to drive health care efficiencies.
Mobile Health Apps Could Disrupt Medical Technology Market– Report
Ernst & Young annual report highlights the importance of emerging “patient-empowering” and “information-leveraging” technologies, and their power to drive health care efficiencies.